QuantumScape Stock Down 63%: Is It Time to Buy for the Long Haul?
QuantumScape faces a volatile path from lab breakthroughs to mass production. This guide breaks down what the stock d...
Learn which low fee index funds beat the market in 2024 and how they can fit into a retirement strategy. This guide highlights top performers and practical steps for investors.
28,527 articlesQuantumScape faces a volatile path from lab breakthroughs to mass production. This guide breaks down what the stock d...
EWJ has fallen 9% in the past 30 days while Japan’s economy rides on fragile oil supply lines. The shift tests the op...
A major hedge fund slashed its stake in Structure Therapeutics, prompting questions about the future path for GPCR-fo...
Policy clarity clears the path for road ahead build-to-rent projects, lifting investor confidence. Still, the pace of...
Rocket Lab and AST SpaceMobile sit on opposite ends of the space-investing spectrum. This guide breaks down what each...
Oil climbs as geopolitical tensions persist and the U.S. weighs whether to tap the Strategic Petroleum Reserve. Trump...
IREN is reshaping its business from crypto mining to AI data centers. This analysis dives into how the move affects i...
What really moved Si-Bone in Q1 2026? Our practical analysis breaks down revenue trends, margins, and the company’s a...
Energy giants Chevron and ExxonMobil trade at new levels, with investors weighing cash flow, LNG ramp-ups, and recent...
Ethereum prices trended lower in late May, while large holders continued to accumulate ETH. Here’s how on-chain activ...
Palantir stock slipped from its peak, triggering questions about value, risk, and timing for late 2026. This guide br...
As Angiodynamics (ANGO) gears up for the 2026 earnings season, investors should focus on orders, backlog, margins, an...